Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Which Biotechs Enjoyed A 'JPM Jump' - And Which Lost Out?

Executive Summary

As participants from this year’s J.P. Morgan Healthcare conference recover from the torrent of new information they were exposed to, Scrip explores which biotechs saw a sustainable shift in their valuations.

Advertisement

Related Content

Migraine Drug Atogepant Delivers Good News When Allergan Needs It Most
Scrip Company Of The Year Celgene In Rude Health Despite Hiccups
J.P. Morgan Notebook Day 4: CRISPR's Not Worried; Theratechnologies' HIV Niche; And Is Moderna's IPO Coming Soon?
Deal Watch: As J.P. Morgan Waits For New Deals, Sanofi Takes Care Of Old Business
Novo's €2.6bn Ablynx Bid Opens The Door For Better Offers

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100240

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel